Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial

Peer Review reports

Original Submission
30 Jun 2023	Submitted	Original manuscript
30 Jul 2023	Reviewed	Reviewer Report - Kirsty Loudon
2 Oct 2023	Author responded	Author comments - Sandip B Patil
Resubmission - Version 2
2 Oct 2023	Submitted	Manuscript version 2
Publishing
4 Oct 2023	Editorially accepted
30 Nov 2023	Article published	10.1186/s13063-023-07701-6

Back to article page